Research Article
Effectiveness and Safety of PD-1 Inhibitors’ Treatment for Patients with Non-Small-Cell Lung Cancer in China: A Real-World Study
Table 2
Relationship between patient clinical characteristics and treatment responses.
| Variables | OR (95% CI) | value |
| Ages (<65 years vs. ≥65 years) | 1.259 (0.632, 2.505) | 0.513 | Smoking history (current or ex-smoker vs. never-smoker) | 0.492 (0.235, 1.027) | 0.059 | Sex (male vs. female) | 1.815 (0.746, 4.420) | 0.189 | Histology (nonsquamous vs. squamous) | 1.315 (0.653, 2.645) | 0.443 | Presence of treating with antibiotic during immunotherapy (yes vs. no) | 1.526 (0.617, 2.567) | 0.526 | Pathological staging (III vs. IV) | 0.755 (0.345, 1.653) | 0.482 | Therapy lines (first-line vs. posterior-line) | 0.610 (0.306, 1.216) | 0.160 | Presence of irAEs (yes vs. no) | 0.947 (0.337, 2.658) | 0.917 | Presence of serious AEs (yes vs. no) | 0.872 (0.403, 1.888) | 0.728 |
|
|